期刊文献+

阿苯达唑前体胶束在猪体内的药动学研究 被引量:4

Pharmacokinetics study of Albendazole pro-micellesin in landrace pig
原文传递
导出
摘要 目的研究阿苯达唑前体胶束在猪体内的药动学。方法采用RP-HPLC法、以甲苯咪唑为内标,测定ig给予英系纯种长白猪阿苯达唑胶束水化溶液和阿苯达唑片剂生理盐水混悬液后,血浆中阿苯达唑、阿苯达唑亚砜、阿苯达唑砜的血药浓度,并计算药动学参数。结果阿苯达唑前体胶束及片剂的血药-时间曲线均为二室模型;二者药动学参数的差异具有统计学意义(P<0.05)。前体胶束相对于片剂的相对生物利用度为230.45%。结论前体胶束在胃肠道的滞留时间增长,吸收增加,清除率较低,延长了药物在组织器官中的消除时间,提高了生物利用度。 OBJECTIVE To study the pharmacokinetic of Albendazole pro - micelles in landrace pig. METHODS Plasma concen- tration of Albendazole, Albendazole sulfoxide, Albendazole sulfone were determined by RP - HPLC, mebendazole as internal standard, after oral administration of suspension of Albendazole tablets saline solution and Albendazole pro - micelles hydration solution, and calculate pharmacokinetics parameter. RESULTS The concentration - time cure of Albendazole pro - micelles and Albendazole tablets were fitted to a two - compartment model and these main pharmacokinetic parameters obtained showed statistical significance. The relative bioavailability of Albendazole pro - micelles compared with tablet by oral administration were 230.45%. CONCLUSION Albendazole pro - micelles, with longer residence time in gastrointestine and low clearance rate, could increase the gastrointestinal absorption, prolong the residence time of Albendazole sulfoxide and sulfone in the blood after oral administration, so it could improves the bioavailability.
作者 陈迹 王建华
出处 《华西药学杂志》 CAS CSCD 北大核心 2014年第5期556-558,共3页 West China Journal of Pharmaceutical Sciences
基金 国家自然科学基金资助项目(批准号:30260119)
关键词 阿苯达唑 前体胶束 药动学 高效液相色谱法 Albendazole Pro - micelles Pharmacokinetic HPLC
  • 相关文献

参考文献7

二级参考文献41

  • 1孙忠贵,刘家祥,王浩,朱克安,张京元,王兰珍,邓永芳.丙硫咪唑治疗多房棘球蚴病的效果观察[J].宁夏医学杂志,1989,11(1):8-9. 被引量:6
  • 2谢沐风.改善溶出度评价方法,提高固体药物制剂水平[J].中国医药工业杂志,2005,36(7):447-451. 被引量:126
  • 3BATZIAS GC, DELLS GA. Reversed-phase liquid chromatographic method with fluorescence detection for the simultaneous delerminalion of albendazole sulphoxide, albendazole sulphone and albendazole 2-aminosulphone in sheep plasma[J].J Chromatogr B Artalyt Techrtol Biomed Life Sci,2004,805 (2) :267 -274.
  • 4CHIAP P,EVRARD B,BIMAZUBUTE MA,et al. Determination of albendazole and its main metabolites in ovine plasma by liquid chromatography with dialysis as integrated sample preparation technique[J].J Chromatogr A,2000:870(1 -2):121-134.
  • 5梁文权.生物药剂学与药物动力学[M].第1版.北京:人民卫生出版社,1998:241-252.
  • 6WHO Informal Working Group on Echinococcosis.Guidelines for Treatment of Cystic and Alceolar Echinococcosis in Humans[J].Bull WHO,1996,74(3):231-242.
  • 7Marriner SE,Morris DL,Dickson B,et al.Pharmacokinetics of Albendazole in Man[J].Eur J Clin Pharmacol,1986,30(6):705-708.
  • 8Horton RJ.Albendazole in Treatment of Human Cystic Echinococcosis:12 Years of Experience[J].Acta Trop,1997,64(1-2):79-93.
  • 9Schipper HG,Koopmans RP,Nagy J,et al.Effect of Dose Increase or Cimetidine Co-administration on Albendazole Bioavailability[J].Am J Trop Med Hyg,2000,63(5-6):270-273.
  • 10Cobo F,Yarnoz C,Sesma B,et al.Albendazole Plus Praziquantel Versus Albendazole Alone as a Pre-operative Treatment in Intra-abdominal Hydatisosis Caused by Echinococcus granulosus[J].Trop Med Int Health,1998,3(6):462-466.

共引文献24

同被引文献52

引证文献4

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部